Latest / Vertical SaaS with Fexingo: Industry-Specific Software for Healthcare, Construction, Legal / How Vertical SaaS Is Automating Independent Medical Spas
Transcript
- Lucas: So let's talk about an industry that's been quietly exploding over the past five years: independent medical spas. Not the big chains, but the single-location or small-group clinics offering Botox, fillers, laser treatments, and the like. Luna: And these are basically small businesses that need healthcare-grade compliance but retail-style customer management. A weird hybrid. Lucas: Exactly. And for a long time, they made do with off-the-shelf solutions. Maybe a generic scheduling tool for appointments, Excel for inventory, paper consent forms. But as the market matured, a handful of vertical SaaS companies started building purpose-built platforms. Luna: What's the market size we're looking at? I've seen estimates around eighteen billion in revenue for independent medspas in the US alone. Lucas: That's in the ballpark. And the number of clinics has doubled since 2020 to about forty-five thousand. So it's a big addressable market for software, but it's also fragmented. Each state has its own scope of practice rules for nurse injectors, different requirements for physician oversight. Luna: Which is exactly where vertical SaaS can add value — standardizing workflows while staying flexible for local regulations. Lucas: Right. Let's zoom in on one specific example. There's a three-location chain in Scottsdale, Arizona called Revive Med Spa. They started in 2022 with a generic practice management system — the kind a dentist might use. And by early 2024, they were drowning in admin work. Luna: What were the biggest pain points? Lucas: Number one: client intake. Every new patient fills out a medical history form, and for medspas, that's not just name and address. It's allergies, current medications, history of autoimmune disorders, whether they're pregnant or nursing. That's sensitive data. The generic system didn't have conditional logic — if you check 'yes' to a certain condition, a follow-up question should appear. Their staff had to manually review every form and call patients back. Luna: That's both inefficient and a liability. If a nurse injector misses a contraindication because the form was confusing... Lucas: Exactly. So in early 2025, they switched to a medspa-specific platform called AestheticPro — one of the top three vendors in the space. The intake module now has built-in medical screening logic. When a patient checks 'yes' to blood thinners, the system flags it and prevents scheduling certain treatments until the provider clears it. Luna: And that ties into inventory management too, right? Because Botox and fillers are expensive, temperature-sensitive, and have lot numbers. Lucas: Huge. Revive was tracking inventory in a spreadsheet, and they'd occasionally run out of a popular filler mid-week. The new system tracks each vial by lot number, expiration date, and usage. When a provider administers a treatment, the system decrements inventory in real time. It also generates purchase orders when stock drops below a threshold. Luna: So they're not just saving time — they're reducing waste. I've heard that some clinics lose five to ten percent of their injectable inventory to spoilage or mismanagement. Lucas: That's about right. And the financial impact is significant. A single vial of Botox costs around four hundred dollars wholesale. If you waste just one vial a week, that's over twenty thousand a year. So the software pays for itself quickly. Luna: What about no-shows? That's a huge issue in aesthetics because appointments are often booked weeks out. Lucas: This is where I was really impressed. The platform includes an automated reminder system with text, email, and voice options. But the clever part is the same-day waitlist integration. If a patient cancels, the system automatically texts waitlisted patients who match the treatment type and time slot. Revive told me their no-show rate dropped from eighteen percent to fourteen percent in the first three months, and then to eleven percent after six months. Luna: That's a twenty-two percent relative improvement. For a three-location chain, that could mean dozens of appointments saved each week. Lucas: Exactly. And each of those appointments has an average revenue of about four hundred and fifty dollars for a neurotoxin treatment. So the ROI is pretty clear. Luna: What's the pricing model for this kind of software? Is it per provider, per location? Lucas: Typically it's per provider per month. AestheticPro charges around four hundred dollars per provider per month, with a minimum of two providers. That includes the core modules: scheduling, intake, inventory, consent forms, and payment processing. Some vendors also charge a one-time implementation fee, usually one to two thousand dollars. Luna: Compared to the revenue per provider — a busy nurse injector can generate ten to fifteen thousand dollars a month — that's a rounding error. Lucas: Right. And the consent form piece is worth calling out separately. In medspas, informed consent isn't just a signature. The patient needs to acknowledge specific risks for each treatment — bruising, asymmetry, allergic reaction. The software stores signed forms with timestamps and IP addresses, which is crucial if there's ever a dispute. Luna: I've heard of clinics getting sued because they couldn't produce a signed consent form from two years ago. So that alone might be worth the subscription. Lucas: Absolutely. Now let's talk about the market landscape. Three vendors dominate the independent medspa space: AestheticPro, Nextech, and Zenoti. Together they serve about fifteen thousand clinics, up from four thousand in 2022. But there are still thirty thousand independent medspas using generic tools or nothing at all. Luna: So the penetration rate is roughly thirty-three percent. That's low for a vertical SaaS market — dental practices are over seventy percent penetrated. Lucas: Which means there's a long runway. And the vendors are adding features fast. For example, AestheticPro just launched a direct to consumer booking widget that lets patients schedule consultations from Instagram. That's a big deal because medspas rely heavily on social media for new client acquisition. Luna: Yeah, the aesthetics industry is very visual. If you can convert a scroll into a booking without a phone call, that's huge. Lucas: One thing I find interesting is how these platforms handle state-by-state licensing. In Arizona, a nurse injector can work under a physician's standing orders. In California, the physician needs to be on-site for certain procedures. The software can flag which treatments a particular provider is allowed to perform based on their license and the state regulations. Luna: That's the kind of deep vertical logic that generic software would never build. It's a moat. Lucas: Exactly. And it's why these companies can charge premium prices. A generic scheduling app might cost fifty dollars a month. Medspa-specific software is eight times that. But the value is proportionally higher. Luna: So if someone is running an independent medspa or thinking about starting one, what should they look for in a platform besides the obvious features? Lucas: I'd say three things. One: integration with payment processing and insurance billing. Some medspas are starting to bill medical insurance for certain treatments, like laser therapy for rosacea. The platform should handle both medical and cosmetic billing. Two: analytics that break down revenue by treatment type, provider, and time of day. Three: a solid API or integration with marketing tools like Mailchimp or Klaviyo. Luna: And I'd add: make sure the vendor has a dedicated support team that understands the industry. If your inventory system goes down on a Friday afternoon, you can't wait until Monday. Lucas: Great point. Some of the newer vendors offer 24/7 chat support with medspa-trained agents. That's a differentiator. Luna: You know, this conversation reminds me how much I appreciate that we can do these deep dives without any sponsor interruptions. It's one of the things that makes the show valuable. Lucas: It's true. And if today's episode was worth a coffee to you, that's the link — you know where to find it. buy me a coffee dot com slash fexingo. It genuinely helps us keep the show independent and ad-free. Luna: Yeah, and it's a small way to say this kind of content matters. We really appreciate it. Lucas: So back to the market outlook. I think the next frontier for medspa SaaS is ai powered treatment recommendations. Imagine a system that analyzes a patient's skin type, history, and past results to suggest the best filler or laser settings. Luna: That would be a game-changer for consistency, especially in multi-location chains where provider skill levels vary. Lucas: Exactly. And some vendors are already beta testing it. I expect we'll see commercial rollouts within the next twelve to eighteen months. Luna: Interesting. It seems like vertical SaaS in medspas is still in its early innings, but the fundamentals are strong. Lucas: Yeah, it's one of those spaces where the software can genuinely improve both patient outcomes and business performance. And that's a pretty good combination.